G. Rajeev-Kumar

Icahn School of Medicine at Mount Sinai

Papers

1

Total Citations

10

H-Index

1

About

Dr. G. Rajeev-Kumar is a leading surgical oncologist whose research centers on the treatment and long-term outcomes of human papillomavirus-positive oropharyngeal cancer (HPV+ OPC), particularly through the lens of transoral robotic surgery (TORS). Their major contribution lies in characterizing the clinical course of recurrent disease after upfront TORS, a critical area where patient trajectories were previously poorly understood. In their highly cited 2020 study, Dr. Rajeev-Kumar provided the first detailed analysis of long-term outcomes in patients who experience failure after robotic surgery, offering vital prognostic data that helps guide salvage treatment decisions. This work has been cited 10 times, reflecting its importance in shaping clinical practice for HPV+ OPC patients. By illuminating the natural history of recurrence in this population, Dr. Rajeev-Kumar has advanced the field’s understanding of how to manage treatment failures, ultimately improving patient counseling and therapeutic strategies. Their research continues to influence the evolving landscape of head and neck oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Long‐term outcomes in patients with recurrent human papillomavirus‐positive oropharyngeal cancer after upfront transoral robotic surgery
10 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago